The Functioning Assessment Short Test (FAST): Clinically meaningful response threshold in patients with major depressive disorder receiving antidepressant treatment
-
Published:2024-10
Issue:
Volume:363
Page:634-642
-
ISSN:0165-0327
-
Container-title:Journal of Affective Disorders
-
language:en
-
Short-container-title:Journal of Affective Disorders
Author:
Christensen Michael CronquistORCID,
Schmidt Simon Nitschky,
Grande IriaORCID
Reference60 articles.
1. Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: an updated analysis of efficacy and tolerability;Adair;J. Affect. Disord.,2023
2. A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms;Baldwin;J. Affect. Disord.,2016
3. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: a short-term, randomized, double-blind, exploratory study;Baune;J. Affect. Disord.,2018
4. Lifetime psychotic symptoms, subthreshold depression and cognitive impairment as barriers to functional recovery in patients with bipolar disorder;Bonnín;J. Clin. Med.,2019
5. Thresholds for severity, remission and recovery using the functioning assessment short test (FAST) in bipolar disorder;Bonnín;J. Affect. Disord.,2018